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Setting Priorities in Global Child Health Research Investments: Universal 
Challenges and Conceptual Framework
Increasingly, there is a need for national governments, 
public-private partnerships, private sector and other fund-
ing agencies to set priorities in health research invest-
ments in a fair and transparent way. A process of priority 
setting is always an activity driven by values of wide range 
of stakeholders, which are often conflicting. This process 
always occurs in a highly specific context (eg, agreed poli-
cies and targets in terms of disease burden reduction and 
time limit, defined geographic space, population and spe-
cific health problems).
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Child Health and Nutrition Research Initia-
tive (CHNRI) held a series of expert meetings 
during which a list of 20 universal challenges 
inherent to research prioritization was iden-
tified. Based on these challenges, several key 
concepts were proposed and defined, includ-
ing the boundaries of health research, its main 
domains, and possible criteria for prioritiza-
tion between competing research investment 
options. If accepted, these concepts could 
form a basis for a transparent decision-making 
framework for setting priorities in health re-
search investments.
CHNRI first proposed that “health re-
search” funded by public funds should be re-
garded as an activity undertaken to generate 
presently non-existing knowledge that will 
eventually be used to reduce the existing dis-
ease burden (or other health-related prob-
lem) in the population that provided funding. 
Three universal and non-overlapping domains 
of health research were proposed as follows: 1) 
research to assess the burden of disease and its 
determinants; 2) research to improve the per-
formance of the existing capacities to reduce 
disease burden; and 3) research to develop 
new capacities to reduce the disease burden (or 
other problem). The focus on disease burden is 
aligned with internationally agreed goals, but 
it can also be changed to address differenc-
es in interests of the investors, such as patent-
able products for private sector. An approach 
to systematic listing of all competing research 
avenues, options, and questions is suggested 
along with a framework for identifying criteria 
that can discriminate between characteristics 
of research questions (eg, answerability, ethics, 
effectiveness, deliverability, affordability, sus-
tainability, maximum potential impact on dis-
ease burden, equity, and others).
CHNRI proposes a new approach to un-
dertaking health research priority setting in a 
fair and transparent way, respecting principles 
of risk-neutral investing. The process brings 
together the investors, a group of technical ex-
perts, and a larger number of representatives 
for various other stakeholders. Investors are a 
part of the process from the outset; they are 
assisted in defining the context, expected “re-
turns” on the investments, and their risk pref-
erences. The role for technical experts is to 
systematically list the competing research in-
vestment options and to use a set of criteria to 
discriminate between research options accord-
ing to their likelihood of reaching the targets. 
The stakeholders can then weigh different cri-
teria according to their system of values to in-
form the investors on research priorities.
It is estimated that more than US$130 
billion are invested globally into health re-
search each year and the amount has been 
increasing steadily over the past decade (1). 
Still, proposals for health research funding 
are far exceeding the available resources. In-
creasingly, there is a need to set priorities in 
health research investments in a fair and le-
gitimate way, using a sound and transparent 
methodology. In 2005, CHNRI launched 
a project to develop a systematic methodol-
ogy for setting priorities in health research 
investments and to apply it to child health 
(2). This effort was motivated by a notion 
that current research investment prioritiza-
tion approaches suffer from many shortcom-
ings, which may partly be responsible for the 
persisting high levels of mortality in children 
globally (3-5). Commission on Health Re-
search for Development stated that “only 5% 
of global spending on health research in 1986 
was devoted to health problems in develop-
ing countries, where 93% of the world’s bur-
den of ‘preventable mortality’ occurred” (6). 
Leroy et al (3) determined the proportion of 
research on childhood mortality directed to-
ward better medical technology (ie, toward 
improving old technology or creating new 
technology) compared with research on tech-
nology delivery and utilization. They found 
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that 97% of grants were allocated to devel-
oping new technologies, which could reduce 
child mortality by 22% – a one-third reduc-
tion of what could be achieved if the existing 
technologies were fully utilized (3). Further-
more, in terms of financial support for health 
systems and policy research, the “10/90 gap” 
persists and health systems research receives 
very little funding (7). The World Report on 
Knowledge for Better Health: Strengthening 
Health Systems reported similar conclusions 
(8). All these sources implied that large dis-
proportion existed between the investments 
in different types of health research, different 
diseases contributing to overall burden, and 
between the health needs of the wealthy and 
the poor.
One of the trends that have been observed 
is that certain type of research has persistently 
been awarded funds and, therefore, attracted 
scientists, while other crucial research, such as 
child health epidemiology, which many not be 
as attractive and likely to be funded remained 
neglected (5,9). Our concern is that the past 
several decades of rewarding new, attractive, 
and original ideas, whereby little concern was 
given to the usefulness of the generated new 
knowledge for reduction of persisting disease 
burden in the society, has led to a dramatic in-
crease in the number of basic research studies 
and growth of impact factors of the journals 
that publish such research (5). This process 
inevitably led to an opening of many new and 
exciting research avenues, but there have been 
only few examples where the full potential of 
the new knowledge was realized at the level of 
public health, ie, used to meet the needs of the 
community/society. This is particularly un-
welcome because the contributions from tax-
payers are frequently the main source of fund-
ing for health research investments, and it 
may (to an extent) explain the ongoing lack of 
progress toward achieving substantial disease 
burden reduction across the developing world 
(3). Only recently, these issues have gained 
more attention (10-12).
The examples above point to the dangers 
of the status quo, inconsistencies, and imbal-
ances in investing, relative lack of transparen-
cy, accountability to high-level goals and stra-
tegic directions, difficulties in determining 
where particular research fits in the process 
of knowledge translation, and similar issues. 
Since May 2005, CHNRI organized a se-
ries of meetings and workshops that involved 
more than 100 experts in global child health 
from different backgrounds. During those 
meetings, a review of existing principles and 
practice of research priority setting was un-
dertaken (4) and a strategy of involving all the 
stakeholders in the process was defined (13). 
Those two papers were the first in the series of 
five papers describing the CHNRI methodol-
ogy that was prepared as a result of the meet-
ings.
The meetings also highlighted a need for 
defining some universally observed challeng-
es and agreeing on several key concepts that 
could be helpful in resolving the challenges. 
A consensus over those concepts would en-
able systematic, transparent, and rational so-
lutions to the challenges that were identified 
with respect to research investment priority 
setting. In this paper, which is the third pa-
per of the series on CHNRI methodology, we 
exclusively focus on those universal challeng-
es and propose a solution in a form of con-
ceptual framework that should serve to sur-
mount the challenges through the CHNRI 
priority setting process. Information on the 
historic approaches, current principles, and 
practice of priority setting, strategies of involv-
ing the stakeholders, specific guidelines for im-
plementing the CHNRI methodology, and its 
validation and comparison with other similar 
methodologies can be found in other papers of 
this series (4,13), and these issues are not a fo-
cus of this particular paper.
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Universal challenges in setting priorities 
in health research investments
Discussions between experts of different back-
grounds were moderated by CHNRI at sever-
al meetings and workshops during 2005 and 
2006. They highlighted some universal chal-
lenges that any priority setting exercise in 
health research investments will eventually 
have to face (Table 1).
The first challenge is deciding who should 
be involved in the process of setting research 
priorities. It was agreed that one important re-
quirement should be that the priority setting 
process involves those who invest in health re-
search from the outset. The shortcoming of 
several previously proposed methodologies 
driven by technical experts was that, although 
they resulted in sound recommendations, they 
were rarely implemented by the investors sub-
sequently (4). It is therefore important that 
investors are involved in the process from the 
start. Still, they should seek assistance from 
technical experts and numerous other stake-
holders to better understand the context in 
which investments are performed. This con-
text involves time frame (long-term vs short-
term expectations), space (geographic bound-
aries likely to be affected by investments), 
magnitude and urgency of the problem (ie, 
burden of disease, disability, or death), and ex-
isting and agreed investment policies and tar-
gets to which political commitment has been 
made.
Based on the understanding of the con-
text, investors can make informed decisions in 
terms of expectations from their investments 
and their risk preferences. Discussions with 
technical experts and stakeholders should as-
sist them in addressing further 3 universal 
challenges – defining what constitutes a health 
research investment option/opportunity; de-
fining what constitutes the expected “return” 
on this investment; and defining what consti-
tutes a potential “risk” in this investment. The 
CHNRI’s solution to defining what consti-
tutes a “research investment option” has been 
described in detail in our earlier work (2,5). 
We proposed previously (5) that an invest-
ment option in health research where public 
funds are used should be defined as a research 
activity that not only produces new knowl-
edge but also incorporates a vision of imple-
mentation of this knowledge to reduce the 
burden of disease and disability and improve 
health. However, different investors will have 
different expectations on “returns” from such 
investment options. While those who are in 
charge of public funds may be interested in re-
duction of the persisting disease burden as an 
appropriate “return” of their health research 
investment, funders of academic institutions 
may be seeking “high impact,” visible publi-
cations, while funders from the industry may 
Table 1. Universal challenges in setting priorities in health re-
search investments identified by Child Health and Nutrition Re-
search Initiative experts.
Challenges in setting priorities:
 1. Deciding who should be involved in the process of setting research 
   priorities
 2. Defining what constitutes a health research investment option 
   opportunity
 3. Defining what constitutes the expected “return” on the investment
 4. Defining what constitutes a potential “risk” in the investment 
 5. Finding a way of dealing with uncertainty of health research outcomes
 6. Defining health research, its boundaries, and its levels of “depth”
 7. Systematic listing of many competing research investment options
 8. Defining what is meant by “priority setting” in the context of health 
   research
 9. Defining criteria relevant to priority setting in health research 
   investments
10. Comparing different domains of health research using the same 
   criteria
11. Development of a simple quantitative way to rank competing research 
   options
12. Limiting the potential of personal biases to substantially influence the 
   outcome
13. Ensuring that priority setting process is fully transparent
14. Ensuring that it can be repeated and validated
15. Ensuring that it is flexible and adjustable to all contexts and levels of 
   application
16. Ensuring that it is iterative with a feedback loop, instead of a one-way 
   process
17. Ensuring that it is perceived by the users as legitimate and fair
18. Ensuring that it is simple and intuitive enough to become popular 
   among users
19. Linking quantitative ranks of research options with specific investment 
   decisions
20. Involving stakeholders from the wider community into the process
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be primarily interested in patentable products 
that could have commercial value.
A further universal challenge is finding a 
way of dealing with uncertainty of health re-
search outcomes. This challenge reflects per-
ceived difficulties in comparing long-term stra-
tegic basic research that offers great promise in 
reducing disease burden (although the final 
outcome is very uncertain) with short-term re-
search in order to define more efficient means 
of delivering existing interventions that are 
known to be effective. At this point, it would 
again be reasonable for the investors to consult 
technical experts, whose knowledge and exper-
tise can be used to assess likelihoods related to 
answerability of different research investment 
options (ie, the likelihood that the endpoints 
of the research can be reached) within a pre-
cisely defined context.
Further challenges include systematic list-
ing of a seemingly endless spectrum of com-
peting research investment options and com-
paring different domains of health research 
using the same criteria. Again, the CHNRI’s 
solution to this problem has been described in 
detail in implementation exercises of CHNRI 
priority setting process in South Africa (at the 
national level) and for zinc as a risk factor (at 
the global level) (14,15) (Table 2). Potential 
profits and risks from investing in research op-
tions from epidemiological research, research 
on new interventions, or health systems and 
policy research can be compared to each oth-
er according to several criteria, which should 
always include (but are not limited to) their 
answerability, their usefulness (in terms of ef-
fectiveness, deliverability, affordability, and 
sustainability), potential impact on persisting 
disease burden, and effect on equity. A further 
challenge is deciding whether those most fun-
damental criteria need refinement or addition 
of some other criteria.
For example, in different contexts address-
ing of the “answerability” criterion may also 
require a separate assessment related to eth-
ics, existing research capacity, or public ac-
ceptance of research results. The “usefulness” 
(relevance) criterion will, in different con-
texts, be split into criteria that will separately 
assess effectiveness, deliverability, affordabil-
ity, sustainability, and whether a critical gap 
in knowledge is being addressed. The “poten-
tial impact” will occasionally not only assess 
the quantity of potential burden reduction, 
but also its quality– ie, whether this reduction 
is targeting those most heavily affected in the 
population. Table 3 lists some of the possible 
criteria that can be used for setting priorities 
Table 2. Child Health and Nutrition Research Initiative’s proposed framework for systematic listing of investment options in health re-
search, which takes into account the varying ”depth” of proposed research: the three most fundamental and mutually exclusive research 
domains; very broad research avenues within those domains; more specific research options; and very specific research questions
Research domain Research avenue Research option Research question
Health research to assess burden 
of health problem (disease) and its 
determinants
Measuring the burden Many research options 
within each of the 
avenues; research 
options should 
correspond to the level 
of 3-to-5-y research 
programs
Several very specific 
research questions within 
each of the research 
avenues should correspond 
to the title of individual 
research papers
Understanding risk factors (in terms of their relative risks)
Measuring prevalence of exposure to risk factors
Evaluating the efficacy and effectiveness of interventions in place
Measuring prevalence of coverage of interventions in place
Health research to improve 
performance of existing capacities 
to reduce the burden
Health policy analysis
Health system structure analysis
Financing/costs analysis
Human resources
Provision/infrastructure
Operations research
Responsiveness/recipients
Improving existing interventions (their affordability and 
deliverability)
Health research to develop new 
capacities to reduce the burden
Basic, clinical, and public health research to advance existing 
knowledge to develop new capacities
Basic, clinical, and public health research to explore entirely novel 
ideas to develop new capacities
Croat Med J 2008;49:307-317
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between different research investment options 
and questions about each option that could 
address these criteria well.
The next challenge is development of a 
simple quantitative (and intuitive) way to 
score and rank all competing research options 
while addressing all relevant criteria. CHNRI 
recommends that appropriate questions to ad-
dress the chosen criteria need to be developed 
and then posed by the investors to technical 
experts, who will then answer them indepen-
dently from each other. In this way, their ex-
pertise will be used to discriminate between 
competing research options based on strict-
ly defined criteria and their collective opti-
mism toward compliance of each research op-
tion with each criterion will be measured. It 
will also limit the potential of personal biases 
to substantially influence the outcome, which 
was seen as another universal challenge.
Namely, personal opinions of members 
of research panels and the undue influence of 
certain members of the panel can have large 
effect on the decision-making process on re-
search grant awards. The proposed conceptual 
framework for CHNRI methodology ensures 
that technical experts provide their input in-
dependently of each other, and that the final 
scores for each competing research option are 
computed in a highly structured, transparent, 
and systematic way. This ensures that priority 
setting process is fully transparent and that it 
could be repeated and validated. Through ap-
plication of agreement statistics methods, the 
CHNRI methodology can also identify con-
troversial issues (ie, responses with a large vari-
ation in scores among experts).
The above characteristics of the CHNRI 
process should also deal with several other uni-
versal challenges. The flexibility in the choice 
of criteria should ensure that the methods are 
adjustable to all contexts and levels of applica-
tion. They also enable a feedback loop, as the 
process can be repeated after some preset peri-
ods of time and priorities will then change with 
the changing context. Its transparency and clar-
ity of the necessary steps should ensure that it is 
perceived by the users as legitimate and fair.
Finally, the following proposed solutions 
should eventually ensure that the process is seen 
as simple and intuitive enough to become pop-
ular among its users. Many experts from differ-
ent backgrounds should undertake scoring in-
dependently from each other and intermediate 
scores for each investment options could then 
be expressed as the percentage of maximum 
possible points to get awarded for each criteri-
on. The final score can then be computed as a 
Table 3. Some of the possible criteria and related questions proposed by Child Health and Nutrition Research Initiative that can be used 
to discriminate between any two (or more) health research options that compete for investments in order to set research priorities. The 
outcomes of the different criteria will necessarily conflict each other
Criterion Question
Acceptability How likely is the proposed research to be approved, taking into account any possible resistance based on ethical or 
political grounds and public opinion?
Affordability How likely is it that the results will improve affordability of existing policies and programs?
Answerability How likely is it that the objectives will be met given the current state of science and the size of the gap in knowledge?
Applicability How likely is it that the results will be immediately applicable for guiding policies and programs?
Deliverability How likely is it that the results will improve the delivery of existing policies and programs?
Equity How likely is it that the proposed research will benefit those who are most vulnerable to poor child development?
Feasibility How likely is it that the cost of the proposed research will be a feasible investment?
Potential effect on disease burden How likely is the proposed research to lead to significant improvement in disease burden reduction?
Sustainability How likely is it that the results will improve sustainability of existing policies and programs?
Usefulness Given the quality of existing evidence, how likely is it that the proposed research will fill a critical gap in knowledge?
Existing research capacity How likely is it that that the objectives will be met given existing research capacity?
Alignment with other policies How well are the objectives aligned with other existing policies in the society?
Generation of commercial products How likely is it that the proposed research will lead to patents and generate commercial products?
Competitiveness and publication 
impact
How likely is it that the results of the research will be seen as competitive against other ongoing work and be 
accepted for publication in the journals with the highest impact factor?
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mean value of the five intermediate scores, ex-
pressed as a number between 0 and 100%. This 
simple and intuitive quantitative score assigned 
to each research investment option to capture 
its overall value can easily be presented to pol-
icy-makers to guide their decisions and can 
also be combined with the proposed cost of 
research to assess cost-effectiveness of all pos-
sible research options and derive optimal mix 
of funded options through program budgeting 
and marginal analysis (16). This is a way of link-
ing quantitative ranks of research options with 
specific investment decisions.
The final challenge, identified as “univer-
sal,” was how to address opinions and systems 
of values of stakeholders other than investors 
and technical experts (such as government rep-
resentatives, health workers, journalists, legal 
experts, recipients from the wider communi-
ty, and others). While stakeholders’ represen-
tatives may lack technical expertise to list and 
score research options, they could still priori-
tize between the chosen criteria by setting spe-
cific weights on intermediate scores for each 
research option, based on their perception of 
the relative importance of each priority-set-
ting criterion in comparison with others. The 
rank orders of competing research avenues 
may change with the modifying of weights. 
These can also be revised as a result of a feed-
back process or substantial changes in the dy-
namic environment in which the priority set-
ting process is being performed. The problem 
of involving stakeholders is a very complex one 
and CHNRI have recently published a sepa-
rate paper that presented different strategies 
to involve stakeholders into health research 
priority setting process (13).
Conceptual framework for setting health 
research priorities proposed by CHNRI
CHNRI experts agreed that all identified chal-
lenges could eventually be dealt with in a sat-
isfactory way through introduction of a new 
and systematic methodology for setting priori-
ties in health research investments. However, 
a prerequisite for such a methodology/process 
is that an agreement is reached on a very limit-
ed number of key concepts. We present these 
concepts in further text, as they form the ba-
sic framework of the CHNRI priority setting 
method.
Defining health research
In the framework proposed by CHNRI, 
health research is defined as “any activity that 
is undertaken to generate presently non-ex-
isting knowledge that will eventually be used 
to reduce the existing disease burden (or oth-
er health-related problem) in human popu-
lation.” This definition is intended mainly to 
guide the investments of public funding and 
not-for-profit organizations. Instead of dis-
ease burden, the endpoint may also be another 
health problem, such as health promotion nec-
essary to address improvements in child devel-
opment. For private donors, however, the end-
points may be patentable products that would 
have commercial value.
The definition of health research stated 
above, which applies to public funding, should 
be carefully considered, because it has two im-
portant implications as follows:
1) It defines disease burden reduction 
as the perceived “return” of investments in 
health research. This is because the agreed tar-
gets and policies for spending public and not-
for-profit funds are typically defined in terms 
of burden of disease reduction within a spec-
ified time frame. This methodology assists in-
vestment choices to reach those targets in an 
effective way.
2) It sets limits to what should be consid-
ered health research. Setting these limits may 
also attract criticism, but it is an essential first 
step that eventually enables a constructive and 
fair priority setting in health research invest-
Croat Med J 2008;49:307-317
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ments in the real world. For example, a num-
ber of activities in construction, environment, 
and communication technology could even-
tually prove to have considerable positive col-
lateral effects on population health. However, 
if it was not possible to envisage and predict 
these effects on disease burden reduction at 
the time when the activities were proposed 
for funding, then they should not be consid-
ered health research. Also, research on genetics 
of drosophila flies or yeast can bring fascinat-
ing new insights. However, if there is no vision 
at all (if even a blurred or distant one) on how 
the new knowledge generated by those activi-
ties can be used to achieve disease burden re-
duction in human populations, then those ac-
tivities cannot be considered health research 
and should not be considered a funding priori-
ty by the organizations that invest in health re-
search.
Defining main domains of health research
It has already been proposed by the Commis-
sion on Health Research for Development 
that, with respect to their potential to reduce 
existing disease burden, there are 3 broad and 
general domains of health research: 1) health 
policy and systems research, 2) research on 
improvement of the existing health interven-
tions, and 3) research on development of new 
interventions (6). The recent work by CHNRI 
has shown that these domains of health re-
search, although very useful, are neither mutu-
ally exclusive nor universally applicable, which 
would both be desirable properties for a re-
search domain (2,4,5,14,15).
For example, if the health research pro-
posed for funding is relevant at the global lev-
el, such as improvement of existing vaccines to 
increase coverage, then a domain “health re-
search to improve deliverability or affordabil-
ity of an existing intervention” will only be 
relevant to some countries, but not the oth-
ers, depending on their contexts and level of 
investment in health care. Also, “improving 
of the effectiveness of existing interventions” 
cannot be entirely addressed through health 
policy and systems research, as suggested in 
the previous conceptual frameworks (6). Fur-
thermore, epidemiological research features 
all 3 domains, and it is a necessary and impor-
tant component of health research needed to 
inform any priority setting process, but it did 
not receive enough attention.
Much of the “improvement of the existing 
interventions” is reliant on the issues of de-
liverability or affordability. This qualifies it as 
the question for health systems and policy re-
search, which is a different research domain 
from “improvement of existing interventions.” 
Finally, development of new interventions is 
not always achieved through identifying an en-
tirely novel line of research, but also through 
scientific advancements on the existing lines of 
work, which overlaps with the domain of “im-
provement of existing interventions.”
Because of those limitations in the exist-
ing framework (6), we propose an extension 
of that framework in which there are 3 univer-
sal and non-overlapping domains of health re-
search as follows:
1) Health research to assess burden of 
health problem (disease) and its determinants;
2) Health research to improve performance 
of existing capacities to reduce the burden;
3) Health research to develop new capaci-
ties to reduce the burden.
By capacities we consider any means of 
conducting health research – from health fa-
cilities and other infrastructure and equip-
ment to available interventions and human re-
sources. We believe that these three domains 
of health research are universally applicable 
in all contexts and also mutually exclusive. All 
possible health research questions should be 
easily categorized under one of the three do-
mains, which is the advancement over previ-
ous approaches. For practical reasons, the sec-
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ond general domain could be further split into 
“health policy and systems research” and “re-
search to improve the existing interventions.”
Defining priority setting (rationing, resource 
allocation)
In most human communities, ranging from 
the nuclear family to global human popula-
tion, the needs and demands of the individuals 
or groups are greater than the resources that 
are available to fulfill them. Therefore, setting 
investment priorities for meeting those needs 
and demands becomes one of the most impor-
tant issues for the development of any poli-
cy. Because not everyone can immediately get 
their demands fulfilled, some will be fulfilled 
immediately with existing resources, while 
others will be delayed.
These choices are especially difficult to 
make in developing countries, where delaying 
investments often means that a price would 
continue to be paid in human suffering, ill-
ness, and death. Because of this, priority set-
ting requires transparent, legitimate, and fair 
approaches and explicit debate about the prin-
ciples and criteria that would be used to make 
such difficult decisions. Some authors define 
priority setting as “who gets what at whose ex-
pense.” The “what” can be either organs from 
donors, available drugs, or, most common-
ly, funding for different suggested activities. 
Although there is growing interest in priori-
ty setting, there is little consensus on the best 
way to carry it out in a fair and legitimate way 
at different levels (individual, community, na-
tional, or global) (4,17,18).
An important concept that we propose 
here is understanding that priority setting is 
not an exact science, process, or method. The 
reason for introducing this concept are the 
experiences with alternative priority-setting 
methods, such as Combined Approach Ma-
trix, “value of information” approach, or the 
tools used by Council on Health Research for 
Development (4). These methods have all been 
carefully developed and validated with the aim 
to become very exact, consistent, and repeat-
able. However, the variety of contexts in which 
priority setting occurs and “returns” on invest-
ments expected by different donors are so large, 
that we believe it would not be possible to de-
velop a “one-fits-all” method with a fixed set of 
criteria and processes. The successful method 
that will have a chance to become accepted and 
popular will need to show very large flexibil-
ity in design to be readily tailored to different 
contexts and purposes. Priority setting is a “sci-
ence” intending to serve the needs of a com-
munity or a society at a specific point in time, 
within given policy, context, time limit, and fi-
nancial constraints. It is value-driven and there 
are many interested stakeholders who will nec-
essarily promote a diverse set of opinions and 
values. There are also many possible criteria ac-
cording to which priorities could be set, some 
of them conflicting each other.
The community of health researchers is al-
ready used to the process of priority setting in 
which they submit their research proposals for 
funding and most of them get rejected or de-
layed until some later point in time. Only the 
minority of “priority research projects” get 
funded. Therefore, priority setting for invest-
ments into health research is already imple-
mented for many decades by governmental 
and private donor agencies. The key question 
is whether it can be done in a more legitimate, 
fair, transparent, and replicable way (19).
Choice of relevant criteria for priority setting in 
health research investments
The decisions made regularly by investors in 
health research on supporting some of the 
proposed research grants are based on some 
criteria that separate priority projects, that get 
funded from those that get delayed or reject-
ed. The key question is how much those crite-
ria are compatible with what priority setting 
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should be about within our conceptual frame-
work, ie, “serving the needs of a community 
or a society at a specific point in time, within 
given policy, context, time limit and financial 
constraints.”
We have witnessed a publication of sev-
eral millions of research papers as a prod-
uct of investments in health research over the 
past several decades. Have those papers really 
been what society needed most in order to re-
duce its present disease burden? Did they real-
ly generate the new knowledge that was most 
needed and useful in reducing the persist-
ing disease burden? Have they eventually led 
to reductions in disease burden over the past 
several decades that justified the immense in-
vestments made into health research over that 
time period? The criteria most often used by 
panels of experts evaluating the research grant 
proposals is answerability (mainly by judging 
track record and capacity of the group suggest-
ing to undertake the research) and attractive-
ness of the new knowledge that is proposed to 
be generated (mainly in terms of potential for 
later publication in journals with high impact 
factors). Very rarely the panels judge the use-
fulness of the knowledge proposed to be gen-
erated in terms of its potential to contribute 
to reduction of the persisting disease burden 
in the society, although this should be one of 
the main criteria within CHNRI’s conceptual 
framework for health research priority setting. 
The stakeholders can then weigh different cri-
teria chosen by the investors and applied by 
technical experts. This weighing will reflect 
their system of values and guide the investors’ 
decisions on research priorities. The technical 
aspects of the weighing have been addressed in 
detail in our previous work (13).
Conclusions
CHNRI proposes a new approach to under-
taking health research priority setting in a 
fair and transparent way, respecting princi-
ples of maximizing the returns in terms of bur-
den of disease reduction for invested funding. 
The approach is systematic and it attempts to 
overcome a larger list of universal challeng-
es through introduction of several key con-
cepts and proposal of a process that could be-
come useful and popular among the users. It 
is transdisciplinary and it incorporates prin-
ciples ranging from medical (eg, public health 
reasoning), social (eg, concern about equity), 
public opinion (eg, respecting stakeholders’ 
views), ethical (“accountability for reasonable-
ness”), and economic (“program budgeting 
and marginal analysis”) disciplines. The agreed 
desirable elements of this new process are sum-
marized in Table 4.
Target audience for the proposed CHNRI 
methodology are national governments, pub-
lic-private partnerships, international not-for-
profit agencies, large research funding donors, 
and policy-makers, but it can also be adapted 
to the needs of private sector. We hope that 
these concepts will lead to improved account-
ability and increased attention to evaluation 
of returns on health research investments. In 
principle, it should be possible to evaluate the 
outcome of investment prioritization using a 
framework such as CHNRI’s vs an alternative 
framework (eg, continuation of existing prac-
Table 4. Elements of the Child Health and Nutrition Research 
Initiative methodology for setting priorities in health research in-
vestments – it is a process driven by the investors and assisted 
by technical experts and numerous stakeholders, that results in 
the following seven outcomes.
Elements
1. Understanding the context in which investments are performed 
  (by the investors)
2. Agreeing on expected profits and risk preferences (by the investors)
3. Defining main criteria for priority setting (by the investors)
4. Systematic listing of many competing research investment options 
  (by the experts)
5. Transparent valuation of each research option against each criterion 
  (by the experts)
6. Adjustment of this valuation according to values of the society 
  (by the stakeholders)
7. Combining this adjusted valuation with predicted cost, expected profits 
  and risk preferences to decide on the optimal investment strategy 
  (by the investors)
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tices or using some alternative priority-set-
ting tool). The countries increasingly measure 
and quantify their disease burden in metrics 
such as disability adjusted life years. If a reduc-
tion in disease burden is agreed as a target that 
could partly be achieved through health re-
search investing, then the design of random-
ized controlled trial should be applicable in as-
sessing the reduction in this burden achieved 
through different investment practices – those 
guided by priority setting tools vs alterna-
tive approaches. After a time frame of 5-10 
years, the differences should become appar-
ent and detectable. At that point, if a substan-
tial advantage of the use of framework such as 
CHNRI’s could be demonstrated, investing 
in health research could become a discipline 
guided by sound, transparent, and fair meth-
ods and practices.
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